Skip to content

Prestige Consumer Healthcare PBH Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$2M
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$294K-93.0%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$38K-44.9%
Hims & Hers Health logo
Hims & Hers HealthHIMS
$5.01M+27.5%
Church & Dwight logo
Church & DwightCHD
$16.6M-14.0%
Abbott logo
AbbottABT
$116M-59.6%

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.18B-34.1%
Enterprise value$3.16B-27.3%
P/E11.5×-4.0×
P/S-0.9×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's stock issuance proceeds?
Prestige Consumer Healthcare (PBH) reported stock issuance proceeds of $378K in Q1 2026.
How has Prestige Consumer Healthcare's stock issuance proceeds changed year-over-year?
Prestige Consumer Healthcare's stock issuance proceeds decreased by 84.6% year-over-year, from $2.46M to $378K.
What is the long-term trend for Prestige Consumer Healthcare's stock issuance proceeds?
Over 4 years (2022 to 2026), Prestige Consumer Healthcare's stock issuance proceeds has grown at a -11.7% compound annual growth rate (CAGR), from $7.04M to $4.29M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.